Page 901 - Read Online

Page 12 of 12 Galvez et al. Mini-invasive Surg 2020;4:86 I http://dx.doi.org/10.20517/2574-1225.2020.86

30. Linden D, Linden K, Oparka J. In patients with resectable non-small-cell lung cancer, is video-assisted thoracoscopic segmentectomy a
suitable alternative to thoracotomy and segmentectomy in terms of morbidity and equivalence of resection? Interact Cardiovasc Thorac
Surg 2014;19:107-10.
31. Linden D, Linden K, Oparka J. In patients with resectable non-small-cell lung cancer, is video-assisted thoracoscopic segmentectomy a
suitable alternative to thoracotomy and segmentectomy in terms of morbidity and equivalence of resection? Interact Cardiovasc Thorac
Surg 2014;19:107-10.
32. Ohtaki Y, Shimizu K. Anatomical thoracoscopic segmentectomy for lung cancer. Gen Thorac Cardiovasc Surg 2014;62:586-93.
33. Veronesi G. Robotic lobectomy and segmentectomy for lung cancer: results and operating technique. J Thorac Dis 2015;7:S122-30.
34. Schneider BJ, Daly ME, Kennedy EB, Stiles BM. Stereotactic body radiotherapy for early-stage non?small-cell lung cancer: American
society of clinical oncology endorsement of the American society for radiation oncology evidence-based guideline summary. J Oncol
Pract 2018;14:180.
35. Tamura M, Matsumoto I, Tanaka Y, et al. Comparison between stereotactic radiotherapy and sublobar resection for non-small cell lung
cancer. Ann Thorac Surg 2019;107:1544-50.
36. Yendamuri S, Komaki RR, Correa AM, et al. Comparison of limited surgery and three-dimensional conformal radiation in high-risk
patients with stage I non-small cell lung cancer. J Thorac Oncol 2007;2:1022-8.
37. Puri V, Crabtree T, Kymes S, et al. A comparison of surgical intervention and stereotactic body radiation therapy for stage i lung cancer in
high-risk patients: a decision analysis. J Thorac Cardiovasc Surg 2012;143:428-36.
38. Grills IS, Mangona V, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung
cancer (NSCLC). J Clin Oncol 2010;28:928-35.
39. Forquer J, McGarry R, Kesler K, et al. A matched-pair analysis of sublobar resection and stereotactic body radiotherapy (SBRT) for stage
I NSCLC. Int J Radiat Oncol Biol Phys 2007;69:S492-3.
40. Matsuo Y, Chen F, Hamaji M, et al. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar
resection for stage i non-small-cell lung cancer in patients at high risk for lobectomy: a propensity score matching analysis. Eur J Cancer
2014;50:2932-8.
41. Fernando HC, Timmerman RD. American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: a
randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer. J
Thorac Cardiovasc Surg 2012;144:S35-8.
42. Mahmood S, Bilal H, Faivre-Finn C, Shah R. Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical
patients with Stage I non-small-cell lung cancer? Interact Cardiovasc Thorac Surg 2013;17:845-53.
43. Scanagatta P. Is surgery still worthwhile as compared to stereotactic ablative radiotherapy or CyberKnife in high-risk surgical patients
with stage I non-small-celllung cancer? E-comment. Interact Cardiovasc Thorac Surg 2013;17:853.
44. Snee MP, McParland L, Collinson F, et al. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability
of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with
peripheral stage I non. Pilot Feasibility Stud 2016;2:5.
45. Ettinger DS, Wood DE, Aisner DL, et al. Non-Small cell lung - NCCN clinical practice guidelines in oncology, v1 2021.
46. Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be
comparable to surgery? Int J Radiat Oncol Biol Phys 2011;81:1352-8.
47. Deng HY, Wang YC, Ni PZ, et al. Radiotherapy, lobectomy or sublobar resection? A meta-analysis of the choices for treating stage I non-
small-cell lung cancer. Eur J Cardio-thoracic Surg 2017;51:203-10.
48. Chen H, Laba JM, Boldt RG, et al. Stereotactic ablative radiation therapy versus surgery in early lung cancer: a meta-analysis of
propensity score studies. Int J Radiat Oncol Biol Phys 2018;101:186-94.
49. Iguchi T, Hiraki T, Matsui Y, et al. Survival outcomes of treatment with radiofrequency ablation, stereotactic body radiotherapy,
or sublobar resection for patients with clinical stage I non-small-cell lung cancer: a single-center evaluation. J Vasc Interv Radiol
2020;31:1044-51.
50. Bryant AK, Mundt RC, Sandhu AP, et al. Stereotactic body radiation therapy versus surgery for early lung cancer among US veterans.
Ann Thorac Surg 2018;105:425-31.
51. Wu J, Bai HX, Chan L, et al. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small
cell lung cancer: a national cancer database study. J Thorac Cardiovasc Surg 2020;160:1350-7.e11.
52. Videtic GM, Donington J, Giuliani M, et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: executive
summary of an ASTRO evidence-based guideline. Pract Radiat Oncol 2017;7:295-301.
53. Gierada D, Pinsky P. Survival after detection of stage I lung cancer by screening in the national lung screening trial. Chest 2020;3:34234-5.
54. Horeweg N, Scholten ET, de Jong PA, et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis
of screening test performance and interval cancers. Lancet Oncol 2014;15:1342-50.
55. Senan S, Paul MA, Lagerwaard FJ. Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative
radiotherapy? Lancet Oncol 2013;14:e270-4.
56. Swensen S, Silverstein M, Ilstrup D, et al. The probability of malignancy in solitary pulmonary nodules: application to small
radiologically indeterminate nodules. Arch Intern Med 1997;157:849-55.
57. Palma D, Lagerwaard F, Rodrigues G, Haasbeek C, Senan S. Curative treatment of Stage i non-small-cell lung cancer in patients with
severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys 2012;82:1149-56.